Factor VIII C2 Domain Contains the Thrombin-binding Site Responsible for Thrombin-catalyzed Cleavage at Arg1689 *
暂无分享,去创建一个
T. Koide | K. Nogami | M. Shima | A. Yoshioka | I. Tanaka | K. Hosokawa | A Yoshioka | K Hosokawa | M Shima | M Nagata | T Koide | E. Saenko | K Nogami | E L Saenko | I Tanaka | M Shibata | M. Shibata | M. Nagata | Masanori Nagata
[1] P. Lollar,et al. Structural basis for the decreased procoagulant activity of human factor VIII compared to the porcine homolog. , 1991, The Journal of biological chemistry.
[2] M. Shima,et al. Epitope localization of monoclonal antibodies against factor VIII light chain which inhibit complex formation by factor VIII with von Willebrand factor. , 1991, International journal of hematology.
[3] B. Keyt,et al. Structure of human factor VIII , 1984, Nature.
[4] P. Lollar,et al. Subunit structure and function of porcine factor Xa-activated factor VIII. , 1997, Biochemistry.
[5] G. E. Gilbert,et al. Some factor VIII inhibitor antibodies recognize a common epitope corresponding to C2 domain amino acids 2248 through 2312, which overlap a phospholipid-binding site. , 1995, Blood.
[6] M. Shima,et al. Factor VIII Ise (R2159C) in a Patient with Mild Hemophilia A, an Abnormal Factor VIII with Retention of Function but Modification of C2 Epitopes , 1997, Thrombosis and Haemostasis.
[7] R. Kaufman,et al. Proteolytic requirements for thrombin activation of anti-hemophilic factor (factor VIII). , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[8] P. Lollar,et al. pH-dependent denaturation of thrombin-activated porcine factor VIII. , 1990, The Journal of biological chemistry.
[9] P. Fraker,et al. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. , 1978, Biochemical and biophysical research communications.
[10] H. Hemker,et al. The role of phospholipid and factor VIIIa in the activation of bovine factor X. , 1981, The Journal of biological chemistry.
[11] G. Vehar,et al. Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity. , 1986, Biochemistry.
[12] M. Shima,et al. Abnormal factor VIII Hiroshima: defect in crucial proteolytic cleavage by thrombin at Arg1689 detected by a novel ELISA , 1994, British journal of haematology.
[13] M. Shima,et al. Common inhibitory effects of human anti‐C2 domain inhibitor alloantibodies on factor VIII binding to von Willebrand factor , 1995, British journal of haematology.
[14] R. Houghten,et al. Localization of the binding regions of a murine monoclonal anti-factor VIII antibody and a human anti-factor VIII alloantibody, both of which inhibit factor VIII procoagulant activity, to amino acid residues threonine351-serine365 of the factor VIII heavy chain. , 1988, The Journal of clinical investigation.
[15] E G Tuddenham,et al. Haemophilia A: database of nucleotide substitutions, deletions, insertions and rearrangements of the factor VIII gene, second edition. , 1994, Nucleic acids research.
[16] L. Hoyer. The factor VIII complex: structure and function. , 1981, Blood.
[17] J. Sixma,et al. The effect of von Willebrand factor on activation of factor VIII by factor Xa. , 1990, European journal of biochemistry.
[18] R. Houghten,et al. Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserine. , 1990, Blood.
[19] I. Sussman,et al. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease. , 1977, The Journal of clinical investigation.
[20] P. Lollar,et al. Activation of porcine factor VIII:C by thrombin and factor Xa. , 1985, Biochemistry.
[21] B. Keyt,et al. Expression of active human factor VIII from recombinant DNA clones , 1984, Nature.
[22] G. Knutson,et al. Molecular cloning of a cDNA encoding human antihaemophilic factor , 1984, Nature.
[23] J. Sixma,et al. The effect of thrombin on the complex between factor VIII and von Willebrand factor. , 1987, European journal of biochemistry.
[24] M. Shima,et al. A role for the C2 domain of factor VIII in binding to von Willebrand factor. , 1994, The Journal of biological chemistry.
[25] E. Saenko,et al. The Acidic Region of the Factor VIII Light Chain and the C2 Domain Together Form the High Affinity Binding Site for von Willebrand Factor* , 1997, The Journal of Biological Chemistry.
[26] J. Jesty,et al. A comparison of phospholipid and platelets in the activation of human factor VIII by thrombin and factor Xa, and in the activation of factor X , 1988 .
[27] T. Koide,et al. Role of Factor VIII C2 Domain in Factor VIII Binding to Factor Xa* , 1999, The Journal of Biological Chemistry.
[28] M. Shima,et al. A Factor VIII Neutralizing Monoclonal Antibody and a Human Inhibitor Alloantibody Recognizing Epitopes in the C2 Domain Inhibit Factor VIII Binding to von Willebrand Factor and to Phosphatidylserine , 1993, Thrombosis and Haemostasis.
[29] P. Fay,et al. Cleavage of Factor VIII Light Chain Is Required for Maximal Generation of Factor VIIIa Activity (*) , 1995, The Journal of Biological Chemistry.
[30] P. Fay,et al. Identification of the binding site for activated protein C on the light chain of factors V and VIII. , 1990, The Journal of biological chemistry.
[31] A. Thompson,et al. Loss of tolerance to exogenous and endogenous factor VIII in a mild hemophilia A patient with an Arg593 to Cys mutation. , 1997, Blood.
[32] R. Kaufman,et al. Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in Chinese hamster ovary cells. , 1989, Molecular and cellular biology.
[33] I. Scharrer,et al. The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies. Recombinate and Kogenate Study Groups. , 1997, Blood.
[34] P. Lollar,et al. Factor VIII and factor VIIIa. , 1993, Methods in enzymology.